Published in J Proteomics on November 26, 2011
Proteomics for discovery of candidate colorectal cancer biomarkers. World J Gastroenterol (2014) 0.89
Proteomic approaches in biomarker discovery: new perspectives in cancer diagnostics. ScientificWorldJournal (2014) 0.85
Linking patient outcome to high throughput protein expression data identifies novel regulators of colorectal adenocarcinoma aggressiveness. F1000Res (2015) 0.80
Cancer cell growth and survival as a system-level property sustained by enhanced glycolysis and mitochondrial metabolic remodeling. Front Physiol (2012) 0.80
Proteomic indicators of oxidation and hydration state in colorectal cancer. PeerJ (2016) 0.75
Chemical composition and the potential for proteomic transformation in cancer, hypoxia, and hyperosmotic stress. PeerJ (2017) 0.75
MicroRNA expression profiles in serous ovarian carcinoma. Clin Cancer Res (2008) 5.54
The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions. Nat Immunol (2008) 4.15
Phase II study of erlotinib in advanced non-small-cell lung cancer after failure of gefitinib. J Clin Oncol (2007) 3.70
Role of KaiC phosphorylation in the circadian clock system of Synechococcus elongatus PCC 7942. Proc Natl Acad Sci U S A (2004) 3.03
Proinflammatory T helper type 17 cells are effective B-cell helpers. Proc Natl Acad Sci U S A (2010) 2.88
Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells. Cancer Cell (2013) 2.38
Robotic versus laparoscopic low anterior resection of rectal cancer: short-term outcome of a prospective comparative study. Ann Surg Oncol (2009) 2.32
The bioenergetic signature of cancer: a marker of tumor progression. Cancer Res (2002) 2.24
The Chromosome-Centric Human Proteome Project for cataloging proteins encoded in the genome. Nat Biotechnol (2012) 2.14
Gene expression signature-based prognostic risk score in gastric cancer. Clin Cancer Res (2011) 1.83
Alternative translation of osteopontin generates intracellular and secreted isoforms that mediate distinct biological activities in dendritic cells. Proc Natl Acad Sci U S A (2008) 1.77
Retinoic acid can enhance conversion of naive into regulatory T cells independently of secreted cytokines. J Exp Med (2009) 1.69
Ras stabilization through aberrant activation of Wnt/β-catenin signaling promotes intestinal tumorigenesis. Sci Signal (2012) 1.56
Thymidylate synthase gene polymorphism affects the response to preoperative 5-fluorouracil chemoradiation therapy in patients with rectal cancer. Int J Radiat Oncol Biol Phys (2010) 1.52
Identical epidermal growth factor receptor mutations in adenocarcinomatous and squamous cell carcinomatous components of adenosquamous carcinoma of the lung. Cancer (2007) 1.49
Suppression of human selenium-binding protein 1 is a late event in colorectal carcinogenesis and is associated with poor survival. Proteomics (2006) 1.44
Colorectal flat neoplasia. Dig Liver Dis (2003) 1.43
Regulation of CD8+ regulatory T cells: Interruption of the NKG2A-Qa-1 interaction allows robust suppressive activity and resolution of autoimmune disease. Proc Natl Acad Sci U S A (2008) 1.43
Altered cortical excitability in patients with untreated obstructive sleep apnea syndrome. Sleep Med (2010) 1.43
Transcriptional silencing of the RUNX3 gene by CpG hypermethylation is associated with lung cancer. Biochem Biophys Res Commun (2004) 1.41
Relaxin expression from tumor-targeting adenoviruses and its intratumoral spread, apoptosis induction, and efficacy. J Natl Cancer Inst (2006) 1.40
Homeotic factor ATBF1 induces the cell cycle arrest associated with neuronal differentiation. Development (2005) 1.37
Solid pseudopapillary tumor of the pancreas suggesting malignant potential. Pancreas (2006) 1.31
Plasmodium vivax malaria in the Republic of Korea during 2004-2005: changing patterns of infection. Am J Trop Med Hyg (2007) 1.30
Frequent inactivation of SPARC by promoter hypermethylation in colon cancers. Int J Cancer (2007) 1.28
Intestinal endometriosis mimicking carcinoma of rectum and sigmoid colon: a report of five cases. Yonsei Med J (2009) 1.27
Identification of S100A8 and S100A9 as serological markers for colorectal cancer. J Proteome Res (2009) 1.24
Enhancement of antigen-specific Treg vaccination in vivo. Proc Natl Acad Sci U S A (2010) 1.21
Clinical outcomes and factors related to resectability and curability of EMR for early colorectal cancer. Gastrointest Endosc (2011) 1.19
Noninvasive molecular biomarkers for the detection of colorectal cancer. BMB Rep (2008) 1.18
MicroRNA-494 downregulates KIT and inhibits gastrointestinal stromal tumor cell proliferation. Clin Cancer Res (2011) 1.16
Cordycepin inhibits vascular smooth muscle cell proliferation. Eur J Pharmacol (2008) 1.16
Bcl-B expression in human epithelial and nonepithelial malignancies. Clin Cancer Res (2008) 1.16
Suppression of NF-kappaB signaling by KEAP1 regulation of IKKbeta activity through autophagic degradation and inhibition of phosphorylation. Cell Signal (2010) 1.16
Endoscopic resection for undifferentiated early gastric cancer. Gastrointest Endosc (2009) 1.15
TCR-dependent transformation of mature memory phenotype T cells in mice. J Clin Invest (2011) 1.13
Integrin-linked kinase is required in hypoxic mesenchymal stem cells for strengthening cell adhesion to ischemic myocardium. Stem Cells (2009) 1.13
Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model. Clin Cancer Res (2006) 1.12
Overexpression of high mobility group box 1 in gastrointestinal stromal tumors with KIT mutation. Cancer Res (2003) 1.12
Profiling of vitreous proteomes from proliferative diabetic retinopathy and nondiabetic patients. Proteomics (2007) 1.11
Tumor-associated alterations in caspase-14 expression in epithelial malignancies. Clin Cancer Res (2005) 1.11
Activating mutations within the EGFR kinase domain: a molecular predictor of disease-free survival in resected pulmonary adenocarcinoma. J Cancer Res Clin Oncol (2009) 1.11
Postexperiment monoisotopic mass filtering and refinement (PE-MMR) of tandem mass spectrometric data increases accuracy of peptide identification in LC/MS/MS. Mol Cell Proteomics (2008) 1.10
Analysis of apoptosis protein expression in early-stage colorectal cancer suggests opportunities for new prognostic biomarkers. Clin Cancer Res (2005) 1.10
Analysis of the cellular mechanism underlying inhibition of EAE after treatment with anti-NKG2A F(ab')2. Proc Natl Acad Sci U S A (2010) 1.09
Proteomic alterations of the variants of human aldehyde dehydrogenase isozymes correlate with hepatocellular carcinoma. Int J Cancer (2002) 1.09
Expression of Bcl-2 family member Bid in normal and malignant tissues. Neoplasia (2002) 1.07
Lymphovascular invasion is an important predictor of lymph node metastasis in endoscopically resected early gastric cancers. Oncol Rep (2011) 1.07
Evidence that cisplatin-induced auditory damage is attenuated by downregulation of pro-inflammatory cytokines via Nrf2/HO-1. J Assoc Res Otolaryngol (2008) 1.06
Extracellular signal-regulated kinase 2-dependent phosphorylation induces cytoplasmic localization and degradation of p21Cip1. Mol Cell Biol (2009) 1.06
Inhibition of methylcholanthrene-induced carcinogenesis by an interferon gamma receptor-dependent foreign body reaction. J Exp Med (2002) 1.06
Correlation of KIT and platelet-derived growth factor receptor alpha mutations with gene activation and expression profiles in gastrointestinal stromal tumors. Oncogene (2005) 1.06
Signet ring cell mixed histology may show more aggressive behavior than other histologies in early gastric cancer. J Surg Oncol (2012) 1.06
Nonstructural 5A protein activates beta-catenin signaling cascades: implication of hepatitis C virus-induced liver pathogenesis. J Hepatol (2009) 1.05
Phosphorylation and transactivation of Pax6 by homeodomain-interacting protein kinase 2. J Biol Chem (2006) 1.04
High microsatellite instability predicts good prognosis in intestinal-type gastric cancers. J Gastroenterol Hepatol (2011) 1.04
Selective translational repression of truncated proteins from frameshift mutation-derived mRNAs in tumors. PLoS Biol (2007) 1.04
Colonic pseudoobstruction: CT findings. AJR Am J Roentgenol (2008) 1.04
Amelioration of arthritis through mobilization of peptide-specific CD8+ regulatory T cells. J Clin Invest (2013) 1.03
A chromosome-centric human proteome project (C-HPP) to characterize the sets of proteins encoded in chromosome 17. J Proteome Res (2012) 1.03
Concerted promoter hypermethylation of hMLH1, p16INK4A, and E-cadherin in gastric carcinomas with microsatellite instability. J Pathol (2003) 1.03
H-Ras is degraded by Wnt/beta-catenin signaling via beta-TrCP-mediated polyubiquitylation. J Cell Sci (2009) 1.02
Loss of E-cadherin and MUC2 expressions correlated with poor survival in patients with stages II and III colorectal carcinoma. Ann Surg Oncol (2010) 1.02
Proteomic analysis and molecular characterization of tissue ferritin light chain in hepatocellular carcinoma. Hepatology (2002) 1.01
Differentially expressed proteins in gastrointestinal stromal tumors with KIT and PDGFRA mutations. Proteomics (2006) 1.01
Therapeutic and tumor-specific immunity induced by combination of dendritic cells and oncolytic adenovirus expressing IL-12 and 4-1BBL. Mol Ther (2009) 1.01
Qigong reduced blood pressure and catecholamine levels of patients with essential hypertension. Int J Neurosci (2003) 1.01
CIFTER: automated charge-state determination for peptide tandem mass spectra. Anal Chem (2008) 1.00
Markedly enhanced cytolysis by E1B-19kD-deleted oncolytic adenovirus in combination with cisplatin. Hum Gene Ther (2006) 1.00
Pleiotrophin exhibits a trophic effect on survival of dopaminergic neurons in vitro. Eur J Neurosci (2003) 1.00
ADP-overexpressing adenovirus elicits enhanced cytopathic effect by induction of apoptosis. Cancer Gene Ther (2005) 1.00
Reversing the intractable nature of pancreatic cancer by selectively targeting ALDH-high, therapy-resistant cancer cells. PLoS One (2013) 1.00
Ribosomal protein S3, a new substrate of Akt, serves as a signal mediator between neuronal apoptosis and DNA repair. J Biol Chem (2010) 1.00
Microsatellite instability in sporadic gastric cancer: its prognostic role and guidance for 5-FU based chemotherapy after R0 resection. Int J Cancer (2011) 1.00
Quantitative analysis of phosphopeptides in search of the disease biomarker from the hepatocellular carcinoma specimen. Proteomics (2009) 0.99
Ginsenoside compound K production from ginseng root extract by a thermostable beta-glycosidase from Sulfolobus solfataricus. Biosci Biotechnol Biochem (2009) 0.98
Effects of qigong on blood pressure, high-density lipoprotein cholesterol and other lipid levels in essential hypertension patients. Int J Neurosci (2004) 0.98
Ad-mTERT-delta19, a conditional replication-competent adenovirus driven by the human telomerase promoter, selectively replicates in and elicits cytopathic effect in a cancer cell-specific manner. Hum Gene Ther (2003) 0.98
Macrophage migration inhibitory factor may be used as an early diagnostic marker in colorectal carcinomas. Am J Clin Pathol (2008) 0.98
Identification of MARCKS, FLJ11383 and TAF1B as putative novel target genes in colorectal carcinomas with microsatellite instability. Oncogene (2002) 0.98
The differential impact of microsatellite instability as a marker of prognosis and tumour response between colon cancer and rectal cancer. Eur J Cancer (2011) 0.98
High mobility group box-1 is phosphorylated by protein kinase C zeta and secreted in colon cancer cells. Biochem Biophys Res Commun (2012) 0.97
Diagnostic significance of serum HMGB1 in colorectal carcinomas. PLoS One (2012) 0.97
The crystal structure of ferritin from Helicobacter pylori reveals unusual conformational changes for iron uptake. J Mol Biol (2009) 0.96
Novel substrates of a ribose-5-phosphate isomerase from Clostridium thermocellum. J Biotechnol (2008) 0.96
Identification of circulating endorepellin LG3 fragment: Potential use as a serological biomarker for breast cancer. Proteomics Clin Appl (2007) 0.96
Quantitative analysis of mTRAQ-labeled proteome using full MS scans. J Proteome Res (2010) 0.96
Simple method for quantitative analysis of N-linked glycoproteins in hepatocellular carcinoma specimens. J Proteome Res (2010) 0.96
Integrated glycoproteomics demonstrates fucosylated serum paraoxonase 1 alterations in small cell lung cancer. Mol Cell Proteomics (2013) 0.96
The tumour suppressor PTEN mediates a negative regulation of the E3 ubiquitin-protein ligase Nedd4. Biochem J (2008) 0.96
Conversion shift of D-fructose to D-psicose for enzyme-catalyzed epimerization by addition of borate. Appl Environ Microbiol (2008) 0.95
Proteomic analysis of breast cancer tissue reveals upregulation of actin-remodeling proteins and its relevance to cancer invasiveness. Proteomics Clin Appl (2008) 0.95